John Dobak - 07 Mar 2022 Form 4 Insider Report for DermTech, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Issuer symbol
N/A
Transactions as of
07 Mar 2022
Net transactions value
-$43,305
Form type
4
Filing time
09 Mar 2022, 19:04:21 UTC
Previous filing
16 Dec 2021
Next filing
15 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale $33,370 -2,561 -0.57% $13.03* 448,661 07 Mar 2022 Direct F1, F2
transaction DMTK Common Stock Sale $9,935 -786 -0.18% $12.64* 447,875 08 Mar 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
F2 Includes 660 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
F3 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.